CRRX Stock Overview
CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada.
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$4.59|
|52 Week High||CA$6.94|
|52 Week Low||CA$4.45|
|1 Month Change||-16.09%|
|3 Month Change||-8.93%|
|1 Year Change||-22.73%|
|3 Year Change||6.74%|
|5 Year Change||-68.99%|
|Change since IPO||48.07%|
Recent News & Updates
These 4 Measures Indicate That CareRx (TSE:CRRX) Is Using Debt Extensively
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
|CRRX||CA Consumer Retailing||CA Market|
Return vs Industry: CRRX underperformed the Canadian Consumer Retailing industry which returned 35.1% over the past year.
Return vs Market: CRRX underperformed the Canadian Market which returned 4.3% over the past year.
|CRRX Average Weekly Movement||5.1%|
|Consumer Retailing Industry Average Movement||4.4%|
|Market Average Movement||9.8%|
|10% most volatile stocks in CA Market||16.7%|
|10% least volatile stocks in CA Market||4.2%|
Stable Share Price: CRRX is less volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: CRRX's weekly volatility (5%) has been stable over the past year.
About the Company
CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes.
CareRx Fundamentals Summary
|CRRX fundamental statistics|
Is CRRX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CRRX income statement (TTM)|
|Cost of Revenue||CA$221.10m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.42|
|Net Profit Margin||-6.31%|
How did CRRX perform over the long term?See historical performance and comparison
Is CareRx undervalued compared to its fair value and its price relative to the market?
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CRRX (CA$4.59) is trading below our estimate of fair value (CA$22.11)
Significantly Below Fair Value: CRRX is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CRRX is unprofitable, so we can't compare its PE Ratio to the Canadian Consumer Retailing industry average.
PE vs Market: CRRX is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CRRX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CRRX's PB Ratio (2.6x) is in line with the CA Consumer Retailing industry average.
How is CareRx forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRRX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CRRX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CRRX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CRRX's revenue (8.4% per year) is forecast to grow faster than the Canadian market (6.3% per year).
High Growth Revenue: CRRX's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CRRX's Return on Equity is forecast to be high in 3 years time
How has CareRx performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CRRX is currently unprofitable.
Growing Profit Margin: CRRX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17% per year.
Accelerating Growth: Unable to compare CRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CRRX is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (10.7%).
Return on Equity
High ROE: CRRX has a negative Return on Equity (-23.99%), as it is currently unprofitable.
How is CareRx's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: CRRX's short term assets (CA$90.2M) exceed its short term liabilities (CA$48.8M).
Long Term Liabilities: CRRX's short term assets (CA$90.2M) do not cover its long term liabilities (CA$154.4M).
Debt to Equity History and Analysis
Debt Level: CRRX's net debt to equity ratio (101.8%) is considered high.
Reducing Debt: CRRX's debt to equity ratio has reduced from 635.1% to 136.7% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CRRX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CRRX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is CareRx current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate CRRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate CRRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if CRRX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if CRRX's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as CRRX has not reported any payouts.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. David Murphy has been the President and Chief Executive Officer at CareRx Corporation (formerly known as Centric Health Corporation) since May 1, 2018 and has been its Director since May 09, 2018. He j...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD1.36M) is above average for companies of similar size in the Canadian market ($USD644.63K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
Experienced Management: CRRX's management team is considered experienced (3.5 years average tenure).
Experienced Board: CRRX's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 55.3%.
CareRx Corporation's employee growth, exchange listings and data sources
- Name: CareRx Corporation
- Ticker: CRRX
- Exchange: TSX
- Founded: 2001
- Industry: Drug Retail
- Sector: Consumer Retailing
- Implied Market Cap: CA$211.524m
- Shares outstanding: 46.90m
- Website: https://www.carerx.ca
Number of Employees
- CareRx Corporation
- 20 Eglinton Avenue West
- Suite 2100
- M4R 1K8
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/17 00:00|
|End of Day Share Price||2022/05/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.